Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totalling 600,500 shares, an increase of 19.1% from the June 15th total of 504,000 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 6,005.0 days.
Recordati Industria Chimica e Farmaceutica Stock Down 0.7 %
Shares of RCDTF stock opened at $51.60 on Monday. The firm’s 50 day moving average price is $51.60 and its two-hundred day moving average price is $50.81. Recordati Industria Chimica e Farmaceutica has a fifty-two week low of $51.60 and a fifty-two week high of $51.98.
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last posted its earnings results on Thursday, May 9th. The company reported $0.85 EPS for the quarter. The firm had revenue of $659.94 million for the quarter. Analysts expect that Recordati Industria Chimica e Farmaceutica will post 2.81 EPS for the current year.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Recommended Stories
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- Top Stocks Investing in 5G Technology
- Positive News is Driving This Cancer Drug Maker’s Stock Higher
- How to Calculate Options Profits
- Top 3 Defense Stocks That Should Be on Your Radar
- How to buy stock: A step-by-step guide for beginnersÂ
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.